早期试验显示,PRP注射可以减轻乳腺癌幸存者的更年期症状,无副作用。 PRP injections eased menopause symptoms in breast cancer survivors without side effects, early trial shows.

在Mayo诊所进行的第一阶段试验发现,血浆丰富的血浆(PRP)注射显著改善了乳腺癌幸存者的更年期生殖综合症(GSM)症状,没有癌症复发或治疗中断。 A phase 1 trial at Mayo Clinic found that platelet-rich plasma (PRP) injections significantly improved genitourinary syndrome of menopause (GSM) symptoms in breast cancer survivors, with no cancer recurrences or treatment interruptions. 由病人自己的血液、缓解阴道干燥、疼痛和小便问题(癌症治疗的共同副作用)产生的非激素疗法。 The nonhormonal therapy, derived from patients’ own blood, eased vaginal dryness, pain, and urinary issues—common side effects of cancer treatments. 研究人员计划进行规模更大的第2阶段试验,以确认结果,因为全球统一制度影响高达70%的幸存者,缺乏安全、有效的治疗办法。 Researchers plan a larger phase 2 trial to confirm results, as GSM affects up to 70% of survivors and lacks safe, effective treatment options.